Steadman Philippon Research Institute and Vail Health renew research partnership for five years

Steadman Philippon Research Institute and Vail Health have signed a new five-year agreement renewing their research partnership, building on a decade-long collaboration that began in 2015 and supported work in regenerative medicine as well as studies in cancer and behavioral health.

Steadman Philippon Research Institute and Vail Health announced a renewal of their long-standing partnership under a new five-year agreement on Jan. 28, 2026. The agreement continues collaboration that began in 2015. Over the previous decade the partnership supported scientific growth at both organizations. That work included developments in regenerative medicine and collaborative studies in cancer and behavioral health. Key details: - The renewal is a five-year agreement announced Jan. 28, 2026. - The collaboration originally launched in 2015 and had a ten-year history prior to this extension. - The prior partnership supported major work in regenerative medicine. - Collaborative studies also addressed cancer and behavioral health, and the earlier agreement enabled scientific growth for both groups. Summary: The new five-year agreement extends research cooperation between SPRI and Vail Health and maintains continuity with projects and priorities developed during the past decade. Specific projects or timelines under the renewed agreement were not detailed in the announcement. Undetermined at this time.